Now in public beta

Every claim, checked against its source.

Alethic verifies that every claim in a paper is actually supported by what it cites, catching citation errors and unsupported claims before publication.

Try NowSee how it works
Verification Report
Illustrative example
Supported

“Editing efficiency exceeded 90% in the transfected cell line.”

Evidence

States this — the reported range contains the stated figure.

Cited reference [4]
Misstated

“No significant off-target effects were observed across all tested loci.”

Evidence

States something narrower — minimal activity at the loci tested, not all of them.

Cited reference [11]
Contradicted

“The method outperformed the comparator across every cell type tested.”

Evidence

States the opposite — the comparator scored higher in one tested cell type.

Cited reference [19]

Trusted by researchers at

uOttawaWaterlooUBCTorontoGWUUWUVAUMDNIHQueen'sWesternHowarduOttawaWaterlooUBCTorontoGWUUWUVAUMDNIHQueen'sWesternHoward
The platform

Verify every claim in a paper, end to end.

Upload a manuscript and Alethic decomposes it into atomic claims, retrieves each cited source, and audits citation fidelity, statistical consistency, and figure-text alignment, with full evidence trails behind every verdict.

Verification report · 2024

Efficacy of CRISPR-Cas9 in Mammalian Gene Therapy

Chen, L. · Nakamura, K. · Patel, R. · Williams, D. · Nature Biotechnology · 47/47 refs resolved
Sections
Abstract6
Introduction11
Methods18
Results34
Discussion34
Contradicted9Misstated10Needs a citation7Supported26
Introduction · 11 claims

CRISPR-Cas9 achieved 94% editing efficiency in HEK293T cells under optimized guide-RNA conditions.

Supported
412statistical

CRISPR-Cas9 demonstrated superior editing efficiency compared to TALENs across primary T-cells.

Contradicted
79factual
0 of 2 cited papers we could read state this
7
Comparative editing efficiency in primary human T-cells
“In primary T-cells the comparator reached 82% editing efficiency against 71% for CRISPR-Cas9.”
Contradicts
9
Guide-RNA design and delivery in mammalian cell lines
Doesn't cover
Start verifying today

Every claim,
verified.

Join researchers at 12+ institutions already using Alethic to catch what peer review misses.

Try Now Talk to us
Try Now